Elicera Therapeutics AB (publ) (STO:ELIC)

Elicera Therapeutics AB Statistics

Total Valuation

STO:ELIC has a market cap or net worth of SEK 244.13 million. The enterprise value is 209.21 million.

Market Cap	244.13M
Enterprise Value	209.21M

Important Dates

The next estimated earnings date is Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

STO:ELIC has 48.54 million shares outstanding. The number of shares has increased by 52.64% in one year.

Current Share Class	48.54M
Shares Outstanding	48.54M
Shares Change (YoY)	+52.64%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	51.88%
Owned by Institutions (%)	16.59%
Float	20.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	17.83
PB Ratio	8.05
P/TBV Ratio	8.05
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-16.04
EV / Sales	15.28
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.35

Current Ratio	5.35
Quick Ratio	5.35
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,122.22

Financial Efficiency

Return on equity (ROE) is -48.58% and return on invested capital (ROIC) is -31.95%.

Return on Equity (ROE)	-48.58%
Return on Assets (ROA)	-25.08%
Return on Invested Capital (ROIC)	-31.95%
Return on Capital Employed (ROCE)	-45.26%
Weighted Average Cost of Capital (WACC)	6.32%
Revenue Per Employee	6.85M
Profits Per Employee	-6.52M
Employee Count	2
Asset Turnover	0.40
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +47.08% in the last 52 weeks. The beta is 0.38, so STO:ELIC's price volatility has been lower than the market average.

Beta (5Y)	0.38
52-Week Price Change	+47.08%
50-Day Moving Average	5.63
200-Day Moving Average	5.75
Relative Strength Index (RSI)	38.53
Average Volume (20 Days)	177,249

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:ELIC had revenue of SEK 13.70 million and -13.04 million in losses. Loss per share was -0.31.

Revenue	13.70M
Gross Profit	13.70M
Operating Income	-13.73M
Pretax Income	-13.04M
Net Income	-13.04M
EBITDA	-13.72M
EBIT	-13.73M
Loss Per Share	-0.31

Balance Sheet

The company has 34.92 million in cash and n/a in debt, with a net cash position of 34.92 million or 0.72 per share.

Cash & Cash Equivalents	34.92M
Total Debt	n/a
Net Cash	34.92M
Net Cash Per Share	0.72
Equity (Book Value)	30.33M
Book Value Per Share	0.62
Working Capital	30.33M

Cash Flow

Operating Cash Flow	-15.71M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of -100.23% and -95.24%.

Gross Margin	100.00%
Operating Margin	-100.23%
Pretax Margin	-95.24%
Profit Margin	-95.24%
EBITDA Margin	-100.14%
EBIT Margin	-100.23%
FCF Margin	n/a

Dividends & Yields

STO:ELIC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-52.64%
Shareholder Yield	-52.64%
Earnings Yield	-5.34%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

STO:ELIC has an Altman Z-Score of 11.76 and a Piotroski F-Score of 2.

Altman Z-Score	11.76
Piotroski F-Score	2